Author:
PALA KARA Zeliha,OZTAS Ezgi,OZTURK Dilek,AKYEL Yasemin,TURNA Zeynep,OKYAR Alper,ÖZHAN Gül
Publisher
Clinical and Experimental Health Sciences
Subject
General Materials Science
Reference24 articles.
1. [1] Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet 2010; 376(9742): 687-97.
2. [2] Power DG, Kelsen DP, Shah MA. Advanced gastric cancer - Slow but steady progress. Cancer Treat. Rev. 2010; 36(5): 384-92.
3. [3] Glimelius B, Hoffman K, Sjödén PO, Jacobsson G, Sellström H, Enander LK, Linné T, Svensson C. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996; 7(6): 593-600.
4. [4] Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: Mechanisms of action and clinical strategies. Nat. Rev. Cancer. 2003; 3(5): 330-8.
5. [5] Cancer (American Cancer Society). Learn about cancer. Stomach Cancer. Detailed Guide. October 2, 2016; Available at: http://www.cancer.org/cancer/stomachcancer/detailedguide/index. Accessed October 15, 2016